Open Access Subscription Access
An Analysis of Siddha Management among COVID-19 Positive Patients of TPEC COVID Care Center, Vellore, Tamilnadu — Feedback Report
Siddha's system of medicine is the effective one to reduce the symptoms of many viral illnesses. Siddha's system of medicine in asymptomatic, mild to moderate Covid-19 Positive patients, will make them recognize its effectiveness, reduce the symptoms, and move into the traditional approach towards the deadliest pandemic disease Covid-19. The objective of this study is to evaluate the acceptance and benefit of integrative Siddha management among the mild, moderate and asymptomatic COVID patients through a feedback questionnaire in TPEC COVID Care Center, Vellore, Tamil Nadu (TPECThanthai Periyar Engineering College). 74 asymptomatic, mild to moderate Covid-19 Positive patients were observed 7 days from 14.07.2020 to 30.07.2020 in TPEC COVID Care Center, Vellore, Tamil Nadu. During this period, Siddha medicines were administrated along with Western medicine. At the end of the period, validated feedback questionnaires were used to collect information from 74 participants for evaluating the acceptance and benefit of integrative Siddha management.In the 74 patients of TPEC COVID Care Center, Vellore, 100% were taken the given Siddha drug properly. 82.4% had the most common symptoms and 52.7% had less common symptoms. 16.2% of cases developed gastric acidity and 1.3% developed mild dyspnea as an ADR. 91.8% were recommended the Siddha system to others. 93.2% reported excellent disease progress. 90.7% of Siddha doctors quoted for 'Excellent' service on covid patients. This feedback report explores the three important significance. (a) Siddha medicine having significant effectiveness (b) Siddha medicines have safety in covid-19 patients (c) overall services of Siddha doctors are appreciatable by the patients and Siddha system is recommended to others. This analysis report helps to provide the possibility of the Siddha system for further or future clinical trials.
COVID Care Center, Integrative Medicine, SARS CoV-2, Novel Corona Virus, Siddha System of Medicine.
- Gangarapu K,Sathiyarajeswaran P,Kanakavalli K, Kumar KM, Kumar DR,Shreedevi MS, et al. In silico computational screening of kabasurakudineer - official siddha formulation and JACOM - Novel Herbal Coded Formulation Against SARS-CoV-2 Spike protein [Internet].2020, Apr 13. Available from: https://ssrn.com/abstract=3574412. http://dx.doi.org/10.2139/ssrn.3574412.
- Cyranoski D. 'We need to be alert: scientists fear the second coronavirus wave as China's lockdowns ease. Nature. 2020 [Epub ahead of print]. https://doi. org/10.1038/d41586-020-00938-0
- Zuo MZ, Huang YG, Ma WH, et al. Expert recommendations for tracheal intubation in critically ill patients with novel coronavirus disease. Chin Med Sci J. 2020; 35:105–9. https://doi.org/10.24920/003724
- Camilla R, Mirjam S, Peter S, Gisela B, Guenter F, Claudia W, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. New Engl J Med. 2020; 382(10):970–1. https://doi.org/10.1056/NEJMc2001468
- Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travelers from Wuhan, China, 2020 Jan 20–28. Euro Surveill. 2020;25. https://doi.org/10.2807/1560-7917.ES.2020.25.5.2000062
- Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020 Aug; 584(7820):257–61.
- World Health Organization, Regional Office for South-East Asia traditional herbal remedies for primary health care. WHO Regional Office for South-East Asia. 2010. https://apps.who.int/iris/andle/10665/206024
- Rakulini R. Classification of 4448 Diseases in Siddha System of Medicine - A Review. Journal of Complementary and Alternative Medical Research. 2020; 9(2):46–54. https://doi.org/10.9734/jocamr/2020/v9i230140
- Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptomstesting/symptoms.html?CDC_A A_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fabout%2F symptoms.html.
- Azer SA. COVID-19: Pathophysiology, diagnosis, complications and investigational therapeutics. New Microbes New Infect. 2020; 37. https://doi.rg/10.1016/j.nmni.2020.100738
Abstract Views: 61
PDF Views: 45